The scientific program will include recent advances on the structure, function and regulation of drug metabolizing enzymes and transporters; omics based technologies for drug discovery and for drug/xenobiotic toxicity assessment; physiologic and/or toxicological roles of novel extrahepatic drug metabolizing enzymes; prediction and mechanisms of adverse drug reactions; environmental toxicology and health, and chemical carcinogenesis.

Exciting sessions will be devoted to pharmacoepigenetic and microRNA dependent drug metabolism and action; toxicogenomics, a predictive tool in toxicology and drug development; epigenomics – impact for drug safety sciences; nutrition and cancer prevention; pharmacogenomics and cancer treatment; oxidative stress, DNA damage and repair and biological considerations. Contemporary issues in drug/xenobiotic research including bioengineering of new enzymes, nanotechnology and stem cell research will also be in the scientific program.

For detailed information about the scientific program please select from the links below or from the left-hand navigation bar:

•     Keynote Lectures
  
  
•      Short Courses
  
  
•      Symposia and Plenary Sessions